Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
3 Personalized Medicine Stocks to Buy for Long-Time Returns
07:50am, Monday, 15'th May 2023
Medicine is not always simple. A drug that cures one patient can easily kill another, based on anything from their weight to their genes to anything else.
GSK welcomes Zantac legal ruling in Canada
03:23am, Friday, 12'th May 2023
GSK PLC (LSE:GSK, NYSE:GSK) said it welcomed a legal ruling in Canada that saw a proposed class action made on behalf of users of a heartburn drug thrown out. The Brentford, UK-based pharmaceuticals
Dividend Portfolio Update: April 2023
11:00pm, Wednesday, 10'th May 2023
Markets continue to look shaky, real estate is starting to crack, precious metals doing pretty well but are still manipulated well below true value and the crypto world has started to thaw but nowhere
GSK's vaccine against RSV wins FDA approval
02:41pm, Thursday, 04'th May 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's approval of GlaxoSmithKline's (GSK) vaccine against RSV.
FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season
02:48pm, Wednesday, 03'rd May 2023
Decades after the first attempt was made, an RSV vaccine has finally been approved by the FDA.
FDA approves GSK RSV vaccine
01:56pm, Wednesday, 03'rd May 2023
The Food and Drug Administration on Wednesday approved GSK's GSK vaccine for respiratory syncytial virus (RSV), a highly contagious virus that causes lung and breathing-passage infections.
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
01:08pm, Wednesday, 03'rd May 2023
The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market.
GSK or TECH: Which Is the Better Value Stock Right Now?
12:56pm, Friday, 28'th Apr 2023
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both GSK (GSK) and Techne (TECH). But which of these two companies is the best option for those looking f
GSK Stock: A Value Trap or a Hidden Gem?
12:44pm, Thursday, 27'th Apr 2023
It's a complicated time for GSK (NYSE: GSK ), formerly known as GlaxoSmithKline. Shares of the U.K. pharmaceutical company have been volatile over the past month but have managed to stay in the green
GSK Beats on Q1 Earnings, Lags Sales, Reaffirms 2023 Outlook
12:11pm, Wednesday, 26'th Apr 2023
Though GSK's revenues benefit from strong growth across all segments, the declining COVID-19 antibody sales do not bode well. Management reaffirms its 2023 guidance.
Early ISA investors go for L&G, GSK and Fundsmith, while turning back on passive funds
11:23am, Wednesday, 26'th Apr 2023
Life insurers Legal & General Group PLC (LSE:LGEN) and Aviva PLC (LSE:AV.), banks such as Lloyds Banking Group PLC (LSE:LLOY) and funds including Terry Smith's Fundsmith Equity and income trusts C
Pharma Behemoths GSK, Roche Outplay Covid Declines To Beat Quarterly Calls
09:16am, Wednesday, 26'th Apr 2023
GSK and Roche both outplayed declining Covid-related sales in the first quarter to beat Wall Street's earnings expectations. The post Pharma Behemoths GSK, Roche Outplay Covid Declines To Beat Quarter
Was This Acquisition a Savvy Play by This Big Pharma Stock?
09:00am, Wednesday, 26'th Apr 2023
U.K.-based GSK is buying Canadian biotech Bellus Health for $2 billion. The purchase will include a promising drug candidate for treating chronic cough.
GSK (GSK) Tops Q1 Earnings Estimates
08:24am, Wednesday, 26'th Apr 2023
GSK (GSK) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $1.10 per share a year ago.
GSK Earnings Beat Expectations. Race for RSV Vaccine Leads Pipeline Hopes.
04:46am, Wednesday, 26'th Apr 2023
The pharmaceutical company is vying to bring the first shot for respiratory syncytial virus to market.
